Repository of Research and Investigative Information

Repository of Research and Investigative Information

Hormozgan University of Medical Sciences

Blood malignancies: Case of Iran

(2013) Blood malignancies: Case of Iran. World Applied Sciences Journal.

Full text not available from this repository.

Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

History and purpose: Malignancy diseases are the Second cause of mortality in many countries that in these cases leukemia and lymphoma happen significantly incidence rates throughout the world particularly in Iran which cause remarkable mortality and serious diagnosis and treatment expenditures for both families and health system. Leukemia and lymphoma totally include about 11 percent of cancers in Mazandaran province by this regard they are in the second rank of prevalent cancers in this province. The purpose of this study is a general and specific description of leukemia and lymphoma in Mazandaran province which has not been implemented yet. Materials and methods: In this study, entire patient's data have been reviewed which have had certain diagnosis of leukemia and lymphoma with valid laboratory or pathology reports since 2001-2008. This data is collected by Babol health research site related to Tehran University of Medical Science. This research is a descriptive retrospective study. In this study, incidence rates based on age groups, gender, city of residence and type of malignancy have been calculated and analyzed. Findings: In Mazandaran province, 1146 cases of leukemia and lymphoma have been realized since 2001-2008. Leukemia and lymphoma occurs 5.9 in 100000 persons in average annually. The most incidence rates obtained at age of 70 or above (26.4) and the least ones were at age of 0-9 (2.3).The incidence rates in males and females are 7.1 and 4.8 respectively and the male to female's incidence ratio is 1.5. The most incidence rate is in Babol (7.3) and the least one is calculated in Neka and Tonekabon equally (1.5). According to the type of malignancy, non Hodgkin lymphoma, with 2.5 in 100000 have the most incidence rate and myeloid leukemia with 1.8 in 100000 have the least incidence rate. Conclusion: Given findings indicates clear differences of incidence rate based on age, gender, residence and type of malignancy. Therefore it's suggested that in addition to promote data collecting program, research projects should be programmed to define leukemia and lymphoma risk factors in this province. © IDOSI Publications, 2013.

Item Type: Article
Additional Information: cited By 0
Keywords: Leukemia lymphoma blood malignancy incidence mazandaran
Subjects: QZ Pathology > QZ 200-380 Neoplasms
Depositing User: مهندس هدی فهیم پور
URI: http://eprints.hums.ac.ir/id/eprint/5083

Actions (login required)

View Item View Item